Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.93
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q1 EPS of ($0.93).
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
- Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
